by
John R. Fischer, Senior Reporter | June 17, 2019
• Liability and incentives aligned so the individual or entity best positioned to know the AI system risks and best positioned to avert or mitigate harm do so through design, development, validation, and implementation. When a mandate exists to use AI, the individual or entity issuing the mandate must be assigned all applicable liability. Developers of autonomous AI systems with clinical applications (screening, diagnosis, treatment) are in the best position to manage issues of liability arising directly from system failure or misdiagnosis, and must accept this liability.
The association also plans and encourages other national and state medical societies to identify areas of medical practice where AI can advance the quadruple aim; leverage existing expertise to ensure clinical validation and assessment of clinical applications of AI; form new professional roles and capacities for aiding and guiding healthcare AI systems; and develop practice guidelines for clinical applications of AI.
“There should be federal and state interagency collaboration with participation of the physician community and other stakeholders in order to advance the broader infrastructural capabilities and requirements necessary for AI solutions in health care to be sufficiently inclusive to benefit all patients, physicians, and other healthcare stakeholders,” AMA also said among its recommendations. “AI is designed to enhance human intelligence and the patient-physician relationship rather than replace it.”
Back to HCB News
